Kim et al. (2), Kim et al. (3), Mauceri et al. and Holler et al. used mTOR inhibitors (rapamycin or everolimus) on NSCLC cell lines in vitro [39,81,82,83]. Here, MTOR is linked to non-small cell lung carcinoma.